Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA116018
Max Phase: Preclinical
Molecular Formula: C4H10NO8P
Molecular Weight: 231.10
Molecule Type: Small molecule
Associated Items:
ID: ALA116018
Max Phase: Preclinical
Molecular Formula: C4H10NO8P
Molecular Weight: 231.10
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(NO)[C@H](O)[C@H](O)COP(=O)(O)O
Standard InChI: InChI=1S/C4H10NO8P/c6-2(1-13-14(10,11)12)3(7)4(8)5-9/h2-3,6-7,9H,1H2,(H,5,8)(H2,10,11,12)/t2-,3-/m1/s1
Standard InChI Key: JJQQOJRGUHNREK-PWNYCUMCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 231.10 | Molecular Weight (Monoisotopic): 231.0144 | AlogP: -2.68 | #Rotatable Bonds: 5 |
Polar Surface Area: 156.55 | Molecular Species: ACID | HBA: 6 | HBD: 6 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 1.47 | CX Basic pKa: | CX LogP: -3.08 | CX LogD: -6.42 |
Aromatic Rings: 0 | Heavy Atoms: 14 | QED Weighted: 0.17 | Np Likeness Score: 1.09 |
1. Dardonville C, Rinaldi E, Barrett MP, Brun R, Gilbert IH, Hanau S.. (2004) Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high-energy intermediate and transition-state analogues., 47 (13): [PMID:15189039] [10.1021/jm031066i] |
2. Ruda GF, Campbell G, Alibu VP, Barrett MP, Brenk R, Gilbert IH.. (2010) Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase., 18 (14): [PMID:20598892] [10.1016/j.bmc.2010.05.077] |
3. Yep A, Sorenson RJ, Wilson MR, Showalter HD, Larsen SD, Keller PR, Woodard RW.. (2011) Enediol mimics as inhibitors of the D-arabinose 5-phosphate isomerase (KdsD) from Francisella tularensis., 21 (9): [PMID:21236668] [10.1016/j.bmcl.2010.12.066] |
4. Gabrielli L, Merlo S, Airoldi C, Sperandeo P, Gianera S, Polissi A, Nicotra F, Holler TP, Woodard RW, Cipolla L.. (2014) Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors., 22 (8): [PMID:24680056] [10.1016/j.bmc.2013.08.012] |
5. Gonzalez SN,Mills JJ,Maugeri D,Olaya C,Laguera BL,Enders JR,Sherman J,Rodriguez A,Pierce JG,Cazzulo JJ,D'Antonio EL. (2021) Design, synthesis, and evaluation of substrate - analogue inhibitors of Trypanosoma cruzi ribose 5-phosphate isomerase type B., 32 [PMID:33249135] [10.1016/j.bmcl.2020.127723] |
Source(1):